Skip to main content
VSTMHealthcare

Verastem Inc (VSTM) Insider Trading

In the last 90 days, 2 Verastem Inc (VSTM) insiders reported no open-market purchases and 4 sales totaling $381,484. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Dan PatersonPresident and CEOSale44,121$8.00$352,968
Oct 1, 2026Daniel CalkinsChief Financial OfficerSale2,566$8.00$20,528
Sep 21, 2026Daniel CalkinsChief Financial OfficerSale55$7.70$423.50
Aug 3, 2026Dan PatersonPresident and CEOSale1,302$5.81$7,565
Jun 22, 2026Dan PatersonPresident and CEOSale20,871$4.18$87,241
Jun 22, 2026Daniel CalkinsChief Financial OfficerSale4,089$4.18$17,089
May 4, 2026Dan PatersonPresident and CEOSale806$5.82$4,691

Common questions

VSTM insider trading FAQ

Are VSTM insiders buying or selling?
Over the last 90 days, VSTM insiders were net sellers, reporting $0.00 of open-market purchases and $381,484 of sales.
When was the last VSTM insider purchase?
No open-market insider purchase of Verastem Inc stock was reported in the last 90 days.
Where does VSTM insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Verastem Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.